Monitoring of adverse drug reactions is an important task of pharmacovigilance. Analysis of the regional department of State Expert Center of the Ministry of Health of Ukraine in Zaporizhzhia region

Authors

  • O. V. Kraydashenko Zaporizhzhia State Medical University,
  • I. F. Belenichev Zaporizhzhia State Medical University,
  • R. V. Stets Zaporizhzhia State Medical University,
  • Yu. A. Kosogor State Expert Center of the MoH of Ukraine,
  • L. M. Kaptur State Expert Center of the MoH of Ukraine,

DOI:

https://doi.org/10.14739/2409-2932.2017.1.93450

Keywords:

monitoring, pharmacovigilance, Zaporizhzhia

Abstract

Safety of medicines has always been, is and will be in the public interest as it relates to a wide range of issues related to drug treatment of almost all diseases, affects the vital activities of human and society existence. Analyzing the received reports we can determine medications and its doses, after taking which the side reactions occur most commonly, as well as which drugs’ combination potentiate the development of pharmacotherapy complications. Zaporizhzhia regional department of State Expert Center MoH of Ukraine received 714 reports of adverse reactions of drugs during 2016. Based on the analysis of spontaneous reports which available in Zaporizhzhia regional department of State Expert Center MoH of Ukraine, drugs that cause unexpected adverse reactions, can be placed in the next order: drugs for the treatment and prevention of infectious diseases, cardiovascular medicines, non-steroidal anti-inflammatory drugs, local anesthetics, hormone drugs, vitamin medicines, medicines that affect the function of the gastrointestinal tract, neurotropic drugs, antihistamine drugs, medicines that affect the function of the respiratory system, plasma substitutes and detoxification solutions.

References

Astakhova, A. V., & Lepakhin, V. K. (2004) Neblagoprijatnye pobochnye reakcii i kontrol' bezopasnosti lekarstv [Adverse side effects and drug safety monitoring]. Moscow. [in Russian].

Chekman, I. S., Viktorov, O. P., Horchakova, N. O., & Belenichev, I. F. (2011) Pobichni reaktsii sertsevo-sudynnykh zasobiv : posibnyk dlia studentiv VMNZ Ukrainy [Side effects of cardiovascular drugs. The manual for medical students in Ukraine]. Kyiv. [in Ukrainian].

Viktorov, A. P., Mal´cev, V. I., & Belousov, Yu. B. (Eds.) (2007) Bezopasnostʹ lekarstv. Rukovodstvo po farmakonadzoru [The safety of medicines. Guidance on Pharmacovigilance]. Kyiv: MORION. [in Ukrainian].

Rakhimov, K. D., Pal´gova, L. K., Alenova, A. Kh., Zordinova, K. A., & Kurmanova, B. S. (2004) Spravochnik po pobochnym dejstiyam lekarstvennykh sredstv [Guide to drugs side effects]. Almaty. [in Kazakhstan].

Chekman, I. S., Viktorov, O. P., & Belenichev, I. F. (2007) Farmakolohiia ta klinichna farmakolohiia. Pobichna diia likarskykh zasobiv ta farmakolohichnyi nahliad za bezpekoiu zastosuvannia likiv v Ukraini [Pharmacology and Clinical Pharmacology. Side effects of drugs and pharmacological supervision of the safety of medicines in Ukraine]. Kyiv. [in Ukrainian].

Belousov, Yu. B., & Leonova, M. M. (Eds.) (2002) Osnovy klinicheskoj farmakologii i racionalʹnoj farmakoterapii [Fundamentals of clinical pharmacology and rational pharmacotherapy]. Moscow: Bionoka. [in Russian].

Chekman, I. S. (1980) Oslozhneniya farmakoterapii [Complications of pharmacotherapy]. Kyiv. [in Ukrainian].

Chekman, I. S. (2003) Osnovnye mekhanizmy vzaimodejstviya lekarstvennykh sredstv. [The main mechanisms of drug interactions]. Recepturnyj spravochnik vracha. Kyiv. [in Ukrainian].

Moseley, J. N. (2014) Risk management: a European regulatory perspective. Drug Saf., 27(8), 499–508.

Downloads

How to Cite

1.
Kraydashenko OV, Belenichev IF, Stets RV, Kosogor YA, Kaptur LM. Monitoring of adverse drug reactions is an important task of pharmacovigilance. Analysis of the regional department of State Expert Center of the Ministry of Health of Ukraine in Zaporizhzhia region. Current issues in pharmacy and medicine: science and practice [Internet]. 2017Feb.20 [cited 2024Dec.24];(1). Available from: http://pharmed.zsmu.edu.ua/article/view/93450

Issue

No. 1 (2017)

Section

Original research

License

Authors who publish with this journal agree to the following terms:

    1. Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution License that allows others to share the work with an acknowledgement of the work's authorship and initial publication in this journal.     Лицензия Creative Commons
    2. Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgement of its initial publication in this journal.
    3. Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access)